LifeNome Launches Precision Longevity OS

NEW YORK - April 27, 2025 - PRLog -- LifeNome, a global leader in precision health and systems biology, today announced the official launch of its groundbreaking Precision Longevity OS, the world's first end-to-end operating system for B2B(2C) personalized healthspan and lifespan optimization.

Built on over 1,000 API endpoints and 53 industry solutions, the Longevity OS enables enterprises to offer scientifically validated, hyper-personalized longevity journeys — powered by multi-omics insights, AI-driven analytics, clinical biomarker integration, and telehealth intervention networks.

"We're entering a new era where health isn't just about treating disease, it's about proactively optimizing longevity," said Ali Mostashari, PhD, CEO of LifeNome. "The Precision Longevity OS gives companies across insurance, digital health, pharma, and wellness the tools they need to lead in this new longevity economy."

Key Features and Marketplace Overview

• Multi-Omics Data Integration: DNA, microbiome, methylation, and blood biomarkers.
• Clinical-Grade Capabilities: CLIA/CAP-certified lab testing and certified telehealth providers trained in cardiovascular, metabolic, and chronic disease management.
• Plug-and-Play Deployment: 1,000+ API endpoints, white-label apps, and fully modular components.
• Dynamic Health Optimization: Predictive risk scoring, personalized interventions, continuous health trajectory modeling.
• Marketplace Ecosystem: Solutions for healthspan extension, chronic disease prevention, women's health, mental well-being, fitness, and weight management.

The Longevity OS marketplace empowers partners to rapidly build and scale branded longevity solutions, creating new revenue streams, enhancing customer engagement, and delivering superior health outcomes. The average partner saves 38% in go to market cost and 55% in go to market time for MVPs.

Value Proposition for Clients

• Accelerate Time-to-Market with ready-to-deploy precision health and longevity capabilities.
• Enhance Differentiation through scientifically validated, deeply personalized experiences.
• Drive Higher Retention and LTV by engaging users in ongoing health optimization journeys.
• Unlock New Premium Offerings in the exploding $27 trillion global longevity economy.

About LifeNome
https://www.lifenome.com

Founded in 2016, by top cited scholars in complexity science, computational genomics, and semantic AI, LifeNome is a precision health company pioneering the integration of multi-omics, AI, and systems biology to transform personalized health and longevity. With clients and partners across North America, Asia, and the Middle East, Lifenome has served over 600,000 end users in more than 14 countries globally. CB Insights has named Lifenome an "Outperformer" in a matchup with 15 top precision health companies including Viome, Inside Trackers, Foodsmart and others.